Mariana G Bego
Overview
Explore the profile of Mariana G Bego including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
525
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Bego M, Cote E, Aschman N, Mercier J, Weissenhorn W, Cohen E
PLoS Pathog
. 2015 Jul;
11(7):e1005024.
PMID: 26172439
Plasmacytoid dendritic cells (pDCs) constitute a major source of type-I interferon (IFN-I) production during acute HIV infection. Their activation results primarily from TLR7-mediated sensing of HIV-infected cells. However, the interactions...
12.
Keyes L, Hargett D, Soland M, Bego M, Rossetto C, Almeida-Porada G, et al.
PLoS One
. 2013 Jan;
7(12):e52827.
PMID: 23300789
Human cytomegalovirus (HCMV) is a member of the Herpesviridae family that infects individuals throughout the world. Following an initial lytic stage, HCMV can persist in the individual for life in...
13.
Soland M, Bego M, Colletti E, Porada C, Zanjani E, St Jeor S, et al.
PLoS One
. 2012 Jun;
7(5):e36163.
PMID: 22666319
Background: Mesenchymal stem cells (MSC) are promising candidates for cell therapy, as they migrate to areas of injury, differentiate into a broad range of specialized cells, and have immunomodulatory properties....
14.
Bego M, Mercier J, Cohen E
J Virol
. 2012 Feb;
86(7):3513-27.
PMID: 22301143
BST-2/tetherin is an interferon (IFN)-inducible host restriction factor that inhibits the release of many enveloped viruses and functions as a negative-feedback regulator of IFN production by plasmacytoid dendritic cells. Currently,...
15.
Keyes L, Bego M, Soland M, St Jeor S
J Gen Virol
. 2012 Jan;
93(Pt 4):722-732.
PMID: 22238232
Human cytomegalovirus (HCMV) is a large DNA virus belonging to the subfamily Betaherpesvirinae. Haematopoietic cells of the myeloid lineage have been shown to harbour latent HCMV. However, following terminal differentiation...
16.
Dube M, Paquay C, Roy B, Bego M, Mercier J, Cohen E
Traffic
. 2011 Sep;
12(12):1714-29.
PMID: 21902775
Bone marrow stromal cell antigen-2 (BST-2) inhibits human immunodeficiency virus type 1 (HIV-1) release by cross-linking nascent virions on infected cell surface. HIV-1 Vpu is thought to antagonize BST-2 by...
17.
Bego M, Keyes L, Maciejewski J, St Jeor S
Arch Virol
. 2011 Jun;
156(10):1847-51.
PMID: 21625978
Human cytomegalovirus (HCMV) latency is poorly understood. We previously described a novel HCMV latency-associated transcript, UL81-82ast, coding for a protein designated LUNA (latency unique natural antigen). The aim of this...
18.
Dube M, Bego M, Paquay C, Cohen E
Retrovirology
. 2010 Dec;
7:114.
PMID: 21176220
Viral protein U (Vpu) is a type 1 membrane-associated accessory protein that is unique to human immunodeficiency virus type 1 (HIV-1) and a subset of related simian immunodeficiency virus (SIV)....
19.
Lehmer E, Jones J, Bego M, Varner J, St Jeor S, Clay C, et al.
Physiol Biochem Zool
. 2010 Aug;
83(5):847-57.
PMID: 20695811
Immunocompetence of animals fluctuates seasonally, However, there is little consensus on the cause of these fluctuations. Some studies have suggested that these patterns are influenced by changes in reproductive condition,...
20.
Bego M, Dube M, Mercier J, Cohen E
J Virol
. 2009 Oct;
83(24):13032-6.
PMID: 19793820
The human immunodeficiency virus type 1 (HIV-1) accessory protein Vpu enhances virus particle release by counteracting a host factor that retains virions at the surfaces of infected cells. It was...